news-img
Poloxamer-188 Adjuvant Efficiently Maintains Adaptive Immunity of SARS-CoV-2 RBD Subunit Vaccination through Repressing p38MAPK Signaling

2022-06-21


https://www.mdpi.com/2076-393X/10/5/715

返回列表